# Speed of Recovery of Reversal of Neuromuscular Blockade in Geriatric Patients Undergoing Spine Surgery

> **NCT03112993** · PHASE4 · COMPLETED · sponsor: **University of Missouri-Columbia** · enrollment: 40 (actual)

## Conditions studied

- Spine Surgery

## Interventions

- **DRUG:** sugammadex
- **DRUG:** Neostigmine

## Key facts

- **NCT ID:** NCT03112993
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-30
- **Primary completion:** 2018-08-13
- **Final completion:** 2018-08-14
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03112993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03112993, "Speed of Recovery of Reversal of Neuromuscular Blockade in Geriatric Patients Undergoing Spine Surgery". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03112993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*